Ect-induced amnesia. Organic, including symptomatic, mental disorders
Conditions
Interventions
Intervention 1: Liothyronine, tab 25 mcg, 2 tab/day, since 1day before first ECT until 1 month after last ECT sessions. Intervention 2: Piracetm, 800 mg tab., 2 tab/day, since one day before the first
Prevention
Placebo
Liothyronine, tab 25 mcg, 2 tab/day, since 1day before first ECT until 1 month after last ECT sessions
Piracetm, 800 mg tab., 2 tab/day, since one day before the first session until the last month after the last sessions of ECT
Placebo 2 tab./day, since one day before the first session until the last session of ECT
Sponsors
Behavioral Sciences Reseach Center of Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Psychiatrist documented order of at least 4 session of ECT for the patient, Patient acceptance the collaboration, diagnosis of MDD, BD, or schizophrenia, no MR or dementia Exclusion criteria: ECT, induced delirium, less than 4 ECTs
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Personal information. Timepoint: Before, first, 4th, and last session, & one month after last ECT session. Method of measurement: Wechsler memory scale.;Orientation. Timepoint: Before, first, 4th, and last session, & one month after last ECT session. Method of measurement: Wechsler memory scale.;Mental control. Timepoint: Before, first, 4th, and last session, & one month after last ECT session. Method of measurement: Wechsler memory scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side-effects. Timepoint: All sessionS of appraisal. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMousavi Seyed Ghafur
Behavioral Sciences Research Center of Isfahan University of Medical Sciences
Outcome results
None listed